Qualigen Therapeutics Inc expected to post a loss of $1.40 a share - Earnings Preview

Aixcrypto Holdings

28/03/2023 13:58

* Qualigen Therapeutics Inc  QLGN.OQ   QLGN.O  is expected
to show
a rise in quarterly revenue when it reports  results on March 30
(estimated). 
    * The Los Angeles California-based  company is expected to
report 
a 6.3% increase in revenue to $1.575 million from $1.48 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Qualigen
Therapeutics Inc
is for a loss of $1.40 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Qualigen
Therapeutics Inc is $33.5​, above​ its last closing price
of $0.90. ​​​

This summary was machine generated March 28 at 12:58 GMT.  All
figures in US dollars  unless otherwise stated